Drug · DIN 02393751
ESBRIET
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 1, 2023; first marketed January 8, 2013.
- Drug Identification Number (DIN)
- 02393751
- Company (DIN owner)
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Pirfenidone L04AX05
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PIRFENIDONE | 267 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 12, 2014: NOC 16437New Drug Submission (NDS) · Merger - buyout
- October 29, 2012: NOC 13778New Drug Submission (NDS) · Manufacturer name change
- October 1, 2012: NOC 13695New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “esbriet”. A notice may cover another product or only some lots: read it to see what it covers.
- ESBRIET (pirfenidone) and the Risk of Drug-Induced Liver InjurySeptember 14, 2020 · Drugs · Product safety
Other DINs named ESBRIET
- DIN 02464489 · Marketed
- DIN 02464500 · Marketed